KR910009241A - 치근막 질환 치료용 서방성 조성물 - Google Patents

치근막 질환 치료용 서방성 조성물 Download PDF

Info

Publication number
KR910009241A
KR910009241A KR1019900018463A KR900018463A KR910009241A KR 910009241 A KR910009241 A KR 910009241A KR 1019900018463 A KR1019900018463 A KR 1019900018463A KR 900018463 A KR900018463 A KR 900018463A KR 910009241 A KR910009241 A KR 910009241A
Authority
KR
South Korea
Prior art keywords
composition
active agent
group
human
concentration
Prior art date
Application number
KR1019900018463A
Other languages
English (en)
Other versions
KR0156918B1 (ko
Inventor
처니얼 대머니 낼린칸트
Original Assignee
리차드 챨스 위트
더 프록터 앤드 갬블 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리차드 챨스 위트, 더 프록터 앤드 갬블 캄파니 filed Critical 리차드 챨스 위트
Publication of KR910009241A publication Critical patent/KR910009241A/ko
Application granted granted Critical
Publication of KR0156918B1 publication Critical patent/KR0156918B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

치근막 질환 치료용 서방성 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 구강 질환을 앓고 있는 인간 또는 하등 동물의 치근막낭내에 또는 주위에 삽입하기에 적합한, 폴리 프로페노산 및 활성 약제를 포함하는 조성물.
  2. 제1항에 있어서, 가교결합되어 거의 무한대의 분자량을 제공하는 개개의 폴리프로페노산 단위의 수 평균 분자량이 약 50,000 내지 1,000,000인 조성물.
  3. 제2항에 있어서, 활성 약제가 소염제, 항생제, 과산화물, 마취제 및 비타민으로 이루어진 그룹중에서 선택되는 조성물.
  4. 제3항에 있어서, 활성 약제의 농도가 약 5 내지 75%인 조성물.
  5. 제4항에 있어서, 활성 약제의 농도가 약 10내지 약 50%이고, 활성 약제가 항생제인 테트라사이클린 그룹중에서 선택되는 조성물.
  6. 제4항에 있어서, 다른 중합체를 추가로 함유하는 조성물.
  7. 제6항에 있어서, 추가의 중합체가 글리코라이드 및 락타이드의 공중합체인 조성물.
  8. 제1항에 따른 조성물을 인간 또는 하등 동물의 치근막 낭내에 투여함으로써 인간 또는 하등 동물의 치근막질환을 치료하는 방법.
  9. 제8항에 있어서, 조성물중의 폴리프로페노산 농도가 약 1 내지 약99%인 방법.
  10. 제9항에 있어서, 활성 약제가 소염제, 항미생물제, 항생제, 과산화물, 마취제 및 비타민으로 이루어진 그룹중에서 선택되는 방법.
  11. 제10항에 있어서, 활성 약제가 항생제인 테트라사이클린 그룹중에서 선택되는 방법.
  12. 제11항중에 있어서, 조성물을 너비가 약 0.1 내지 약 5㎜이고, 두께가 약 0.01 내지 약 2㎜이고, 길이가 약 1내지 약 15㎜인 형태로 성형시키는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900018463A 1989-11-17 1990-11-15 치근막 질환 치료용 서방성 조성물 KR0156918B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US438545 1989-11-17
US07/438,545 US5084267A (en) 1989-11-17 1989-11-17 Sustained release compositions for treating periodontal disease
US438,545 1989-11-17

Publications (2)

Publication Number Publication Date
KR910009241A true KR910009241A (ko) 1991-06-28
KR0156918B1 KR0156918B1 (ko) 1998-11-16

Family

ID=23741037

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900018463A KR0156918B1 (ko) 1989-11-17 1990-11-15 치근막 질환 치료용 서방성 조성물

Country Status (15)

Country Link
US (1) US5084267A (ko)
EP (1) EP0429225B1 (ko)
JP (1) JPH03209312A (ko)
KR (1) KR0156918B1 (ko)
AT (1) ATE133859T1 (ko)
AU (1) AU648279B2 (ko)
CA (1) CA2029047C (ko)
DE (1) DE69025271T2 (ko)
DK (1) DK0429225T3 (ko)
ES (1) ES2082834T3 (ko)
FI (1) FI98125C (ko)
GR (1) GR3018934T3 (ko)
IE (1) IE71930B1 (ko)
NZ (1) NZ236112A (ko)
PT (1) PT95868B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5770588A (en) * 1991-02-11 1998-06-23 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
CA2173109A1 (en) * 1993-10-01 1995-04-13 Kenneth Shyer Kornman Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
ES2163504T5 (es) 1994-05-06 2008-05-16 Pfizer Inc. Formas de dosificacion de liberacion controlada de azitromicina.
EP0778768B1 (en) 1995-06-09 2004-05-26 Euroceltique S.A. Formulations and methods for providing prolonged local anesthesia
US5814331A (en) * 1995-11-13 1998-09-29 Holen; Sheldon Process for inhibiting pathogenic bacteria in the oral cavity and for binding peptide growth factors on surfaces
WO1997049391A1 (en) 1996-06-24 1997-12-31 Euro-Celtique, S.A. Methods for providing safe local anesthesia
US6046187A (en) * 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
IL129951A0 (en) * 1997-07-02 2000-02-29 Euro Celtique Sa Prolonged anesthesia in joints and body spaces
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
DK0942780T3 (da) 1997-09-09 2003-10-27 Lyotropic Therapeutics Inc Overtrukne partikler, fremgangsmåder til fremstilling deraf og anvendelse deraf
AU766959B2 (en) * 1998-04-20 2003-10-30 Genzyme Corporation Drug delivery of proteins from polymeric blends
WO2002058670A1 (en) * 2001-01-25 2002-08-01 Euroceltique S.A. Local anesthetic, and method of use
US20060147394A1 (en) * 2004-12-30 2006-07-06 Ramachandra Shastry Tooth whitening composition containing cross-linked polymer-peroxides
US7125954B2 (en) * 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4568535A (en) * 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
US4892736A (en) * 1983-10-07 1990-01-09 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4764377A (en) * 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4795436A (en) * 1983-11-14 1989-01-03 Bio-Mimetics, Inc. Bioadhesive composition and method of treatment therewith
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4603076A (en) * 1985-03-04 1986-07-29 Norwood Industries, Inc. Hydrophilic foam
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
US4699823A (en) * 1985-08-21 1987-10-13 Kimberly-Clark Corporation Non-layered absorbent insert having Z-directional superabsorbent concentration gradient
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4839215A (en) * 1986-06-09 1989-06-13 Ceramed Corporation Biocompatible particles and cloth-like article made therefrom
US4725629A (en) * 1986-07-18 1988-02-16 Kimberly-Clark Corporation Process of making an interpenetrating superabsorbent polyurethane foam
US4725628A (en) * 1986-07-18 1988-02-16 Kimberly-Clark Corporation Process of making a crosslinked superabsorbent polyurethane foam
US4769414A (en) * 1986-09-08 1988-09-06 Grain Processing Corporation Absorbent compositions
JPH0617300B2 (ja) * 1986-09-22 1994-03-09 サンスタ−株式会社 歯周疾患治療用組成物
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
EP0267617B1 (en) * 1986-11-14 1992-06-24 Theratech, Inc. Penetration enhancement with binary system of cell envelope disordering compounds and lower alcohols
JPH0744940B2 (ja) * 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4818534A (en) * 1987-04-01 1989-04-04 Lee County Mosquito Control District Insecticidal delivery compositions and methods for controlling a population of insects in an aquatic environment
JPH0645535B2 (ja) * 1987-05-20 1994-06-15 サンスタ−株式会社 歯槽骨代謝治療用組成物
IL86802A0 (en) * 1987-06-30 1988-11-30 Vipont Pharma Drug delivery devices
US4900552A (en) * 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms

Also Published As

Publication number Publication date
DK0429225T3 (da) 1996-06-24
EP0429225B1 (en) 1996-02-07
CA2029047C (en) 1995-03-14
ES2082834T3 (es) 1996-04-01
US5084267A (en) 1992-01-28
DE69025271D1 (de) 1996-03-21
KR0156918B1 (ko) 1998-11-16
AU648279B2 (en) 1994-04-21
FI98125B (fi) 1997-01-15
IE904148A1 (en) 1991-05-22
GR3018934T3 (en) 1996-05-31
JPH03209312A (ja) 1991-09-12
PT95868A (pt) 1991-09-30
FI98125C (fi) 1997-04-25
ATE133859T1 (de) 1996-02-15
DE69025271T2 (de) 1996-09-05
IE71930B1 (en) 1997-03-12
FI905681A0 (fi) 1990-11-16
PT95868B (pt) 1997-11-28
CA2029047A1 (en) 1991-05-18
AU6667790A (en) 1991-05-23
NZ236112A (en) 1993-04-28
FI905681A (fi) 1991-05-18
EP0429225A1 (en) 1991-05-29

Similar Documents

Publication Publication Date Title
KR910009241A (ko) 치근막 질환 치료용 서방성 조성물
KR910009243A (ko) 치근막 질환 치료용 서방성 조성물
KR930701987A (ko) 치주 질환을 치료하기 위한 서방성 조성물
KR910009242A (ko) 치근막 질환 치료용 서방성 조성물
US4764377A (en) Intra-pocket drug delivery devices for treatment of periodontal diseases
US4892736A (en) Intra-pocket drug delivery devices for treatment of periodontal diseases
EP0140766B1 (en) Intra pocket drug delivery devices for treatment of periondontal diseases
ATE119391T1 (de) Mittel zur verzögerten freisetzung von chlorhexidin.
RU95109905A (ru) Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта
DK20488A (da) Farmaceutiske praeparater med forlaenget afgivelse
ATE108650T1 (de) Methode und zusammensetzung zur oralen verabreichung von bioaktiven mitteln zur peyer's flecken.
EP1392364B1 (en) Liquid polymer composition for prevention and treatment of the oral cavity diseases
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
BR9611802A (pt) Composições farmacêuticas
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
BR9809117A (pt) Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada
DE69227259D1 (de) Film zur lokalen arzneistoffabgabe für periodontale behandlung
PT83241B (pt) Processo para a preparacao de composicoes de drogas de matriz polimerica, capazes de mascarar o sabor de um ingrediente activo, contendo um polimero tendo uma serie de grupos acido e ester carboxilicos
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
AR022338A1 (es) Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
ZA200600165B (en) Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents
KR920002163A (ko) 의약을 제조하기 위해 중추 신경 작용성 acth 유사체를 사용하는 방법
PT95867A (pt) Processo para a preparacao de uma composicao de libertacao retardada compreendendo um copolimero de lactide e glicolide, para tratamento de doencas periodonticas

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee